Skip to content

Zymeworks ZYME Price / sales

Price / sales at other companies

Pfizer logo
PfizerPFE
2.5×+0.2×
Amgen logo
AmgenAMGN
5.1×+0.2×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
6.9×+1.8×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
28.2×-3,609×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
13.4×-15.4×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
60×+58.2×

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

Based on the most recent quarter.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's price / sales?
Zymeworks (ZYME) reported price / sales of 22.9× in Q1 2026.
How has Zymeworks's price / sales changed year-over-year?
Zymeworks's price / sales increased by 158.0% year-over-year, from 8.9× to 22.9×.
What is the long-term trend for Zymeworks's price / sales?
Over 4 years (2020 to 2025), Zymeworks's price / sales has grown at a -24.1% compound annual growth rate (CAGR), from 56.5× to 18.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.